Blockchain Registration Transaction Record

BioElectronics Launches Drug-Free ActiPatch Pain Therapy in Taiwan

BioElectronics partners with Aphrodite Medical Group to launch ActiPatch, a FDA-cleared drug-free pain therapy device, in Taiwan starting Q2 2026. Learn about this innovative alternative to pharmaceuticals.

This news matters because it represents a significant advancement in global pain management, offering patients a non-invasive, drug-free alternative to traditional pharmaceuticals. With opioid crises and medication side effects being major concerns worldwide, technologies like ActiPatch provide safer options for chronic pain sufferers. The expansion into Taiwan signals growing international acceptance of bioelectronic therapies, potentially reducing healthcare costs and improving quality of life for millions. As populations age and pain management needs increase, such innovations could transform standard care protocols and offer sustainable solutions beyond medication dependency.